This HTML5 document contains 89 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://dx.doi.org/10.1111/
n7http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q58697730
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu n'agostu de 2018 article scientifique publié en 2018 scientific article published on 29 August 2018 im August 2018 veröffentlichter wissenschaftlicher Artikel наукова стаття, опублікована в жовтні 2018 wetenschappelijk artikel
p:P577
wds:Q58697730-C0DF5F73-3E73-4C54-8A1E-1C5B411DAA77
wdt:P577
2018-08-29T00:00:00Z
p:P407
wds:Q58697730-7B89C9BF-14F8-4B6F-9B3C-73E92EF324E0
wdt:P407
wd:Q1860
p:P2860
wds:Q58697730-0FAC0FDF-C9A9-4F8F-BC97-4B5486C601CD wds:Q58697730-170A0941-30A4-4311-87E1-489833D51137 wds:Q58697730-43A2C8CF-49B1-4D6D-83F0-D652AC068722 wds:Q58697730-52E45A44-B9F3-4EB2-81FD-2FC3F2236791 wds:Q58697730-2241AC17-C3CE-44BC-80B6-ED1CC052F2D5 wds:Q58697730-24DAAD71-154F-42C2-9FEA-268A36DD7D12 wds:Q58697730-27C69DE9-72C6-4BE5-9CDD-49D85CC5B7DB wds:Q58697730-35508561-D4EF-429E-8E78-93928CB092A8 wds:Q58697730-63056DE8-73ED-446B-9B4F-BD00BF96431E wds:Q58697730-6B3837DD-C073-42BA-BE51-C971675930AF wds:Q58697730-6E3BD803-E93C-4707-81EF-7950FFBE3F0B wds:Q58697730-5320A580-7DEB-4324-9ABA-7E5B4AE83560 wds:Q58697730-53FF62D0-DD4B-451F-9E10-A9F72DF057A0 wds:Q58697730-5A7ADE08-F55B-4D26-8370-49DCA6B2E526 wds:Q58697730-5ED00102-2BBF-4908-9929-22310BCFCC5D wds:Q58697730-9A5BB3DA-44D7-4801-90BA-CD9878F087E0 wds:Q58697730-9D833322-65ED-4A53-BD3A-25A9F4515CEC wds:Q58697730-8102F64C-30DD-49EB-86DC-C5646F64EFF8 wds:Q58697730-962BE5C6-4E79-4526-8040-322F0B608480 wds:Q58697730-B0DBBDEF-3FCD-43EF-A0C8-2A59F9A46E32 wds:Q58697730-B416405E-973B-4EA4-8DBC-FD415E9C64F4 wds:Q58697730-E9969E94-F25F-4789-A2FE-866479A35D67
wdt:P2860
wd:Q45308066 wd:Q43237633 wd:Q35750062 wd:Q30453797 wd:Q39475482 wd:Q35798073 wd:Q44033076 wd:Q46439302 wd:Q58404248 wd:Q34109559 wd:Q34034507 wd:Q36063800 wd:Q73579235 wd:Q28088754 wd:Q53409128 wd:Q86873821 wd:Q36669593 wd:Q40668115 wd:Q39025033 wd:Q88695273 wd:Q28379428 wd:Q28379259
p:P2093
wds:Q58697730-F9B726E0-30DB-4735-9A8C-82777FE5151B wds:Q58697730-D82E976A-118B-4F27-807B-6ACB8BF72F41
wdt:P2093
Ichiro Tsubouchi Shinichi Watanabe
rdfs:label
Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study
skos:prefLabel
Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study
schema:name
Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study
p:P50
wds:Q58697730-40DA2DED-7AF4-4EA4-A35A-467E4CCD3B60
wdt:P50
wd:Q90198959
p:P1476
wds:Q58697730-40199CA4-8C25-4901-819B-6E58149200D5
wdt:P1476
Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study
p:P304
wds:Q58697730-E159027C-30F9-46E4-9A74-026B8FD2AD71
wdt:P304
1151-1159
p:P31
wds:Q58697730-A067E6B5-BBA9-4AF1-A497-92985B5535E6
wdt:P31
wd:Q13442814
p:P921
wds:Q58697730-6D0906EC-68ED-486B-B9DC-62BB0C417B1B
wdt:P921
wd:Q171171
p:P698
wds:Q58697730-DEA4960C-DFB0-433F-9B25-404161EE89E1
wdtn:P698
n7:30156314
wdt:P698
30156314
p:P1433
wds:Q58697730-A96DC662-FA32-4B30-9F48-4D7F20F00655
wdt:P1433
wd:Q18225322
p:P433
wds:Q58697730-715E4BAE-F4B9-48C9-B800-DA0217A4F1A3
p:P478
wds:Q58697730-CA4AB06B-1CF0-405F-81B7-7B5AF4C82B0C
wdt:P433
10
wdt:P478
45
p:P356
wds:Q58697730-DC5716F2-CB94-4BA4-8757-100A65222998
wdtn:P356
n9:1346-8138.14607
wdt:P356
10.1111/1346-8138.14607
p:P932
wds:Q58697730-CF02BFED-797B-4F01-B1CB-E691F04E9F32
wdt:P932
6220848